{
  "run_timestamp_utc": "2026-01-13T23:52:22.276027Z",
  "universe_note": "Universe: provided packets only (NASDAQ/NYSE-listed common stocks/ADRs). Liquidity gate applied: avg_dollar_volume_20d >= 50,000,000 and price >= 2. Exclusions requiring 5-day % move and dated earnings/catalyst windows could not be fully enforced because packets lack 5-day return and confirmed scheduled event calendars; where catalysts could not be verified as dated within 7 trading days, Catalyst score was capped per rules.",
  "method_version": "v3.0",
  "top5": [
    {
      "rank": 1,
      "ticker": "MUR",
      "name": "Murphy Oil Corporation",
      "exchange": "NYSE",
      "sector": "Energy",
      "current_price": 32.58000183105469,
      "market_cap_usd": 4748920320,
      "avg_dollar_volume_20d": 63038928.296260834,
      "asof_price_utc": "2025-12-09T00:00:00Z",
      "target": {
        "horizon_trading_days": 7,
        "upside_threshold_pct": 10,
        "target_price_for_10pct": 35.838001,
        "base_case_upside_pct_range": [
          10,
          18
        ],
        "bear_case_note": "Oil discovery narrative fades (no follow-on details/confirmation) or crude/oil equities sell off; a break back below short-term moving averages would weaken momentum."
      },
      "primary_catalyst": {
        "title": "Vietnam offshore oil discovery headlines / follow-through newsflow",
        "key_date_local": "2026-01-12",
        "timing": "Anytime",
        "why_it_matters": "Multiple independent headlines describe a 'significant' Vietnam offshore discovery, which can drive near-term repricing via reserve/value expectations and additional appraisal/partner updates.",
        "sources": [
          {
            "title": "Murphy Oil Makes Southeast Asiaâ€™s Largest Oil Discovery in 20 Years",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-12"
          },
          {
            "title": "Murphy Oil Confirms 'Significant' Oil Discovery offshore Vietnam",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-07"
          },
          {
            "title": "Murphy Oil confirms major oil reserves with HSV-2X well off Vietnam",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-07"
          }
        ]
      },
      "scores": {
        "technical": 8.0,
        "catalyst": 7.0,
        "options": 3.0,
        "sentiment": 4.0
      },
      "composite_score": 5.5,
      "evidence": {
        "technical": {
          "within_5pct_52w_high": true,
          "resistance_level": null,
          "volume_ratio_3d_to_20d": 0.69,
          "rsi14": 67.7,
          "above_ma10_ma20_ma50": true,
          "realized_vol_5d_ann_pct": 39.26
        },
        "options": {
          "call_put_ratio": null,
          "unusual_volume_multiple": null,
          "largest_bullish_premium_usd": null,
          "iv_rank": null,
          "notable_contracts": []
        },
        "sentiment": {
          "twitter": {
            "mention_velocity_vs_7d": null,
            "quality_accounts_est": null,
            "bullish_pct_est": null
          },
          "reddit": {
            "mention_velocity": null,
            "upvote_ratio_est": null
          },
          "stocktwits": {
            "bull_bear_ratio_est": null
          },
          "news_tone": "positive"
        }
      },
      "risk_factors": [
        "Commodity beta: crude price and broader energy risk-on/off can dominate single-name catalysts.",
        "Event follow-through risk: discovery headlines may be partially priced; lack of quantified resource estimates/appraisal timeline can cap upside."
      ],
      "confidence": "SPECULATIVE",
      "data_gaps": [
        "Options data unavailable in packet; options score capped at 3.0.",
        "Social sentiment data unavailable in packet; sentiment score capped at 4.0.",
        "No confirmed scheduled catalyst date/time within next 7 trading days beyond newsflow; catalyst scored as breaking/news-driven rather than scheduled.",
        "5-trading-day % move not provided; cannot enforce >15% exclusion rule."
      ]
    },
    {
      "rank": 2,
      "ticker": "RIG",
      "name": "Transocean Ltd.",
      "exchange": "NYSE",
      "sector": "Energy",
      "current_price": 4.449999809265137,
      "market_cap_usd": 4725182464,
      "avg_dollar_volume_20d": 140063275.04926085,
      "asof_price_utc": "2025-12-09T00:00:00Z",
      "target": {
        "horizon_trading_days": 7,
        "upside_threshold_pct": 10,
        "target_price_for_10pct": 4.895,
        "base_case_upside_pct_range": [
          10,
          20
        ],
        "bear_case_note": "If contract/backlog momentum stalls or oil services sell off; a failure to hold above short-term MAs would weaken the setup."
      },
      "primary_catalyst": {
        "title": "New rig contract wins / backlog additions",
        "key_date_local": "2026-01-06",
        "timing": "Anytime",
        "why_it_matters": "Contract awards and backlog additions can shift near-term earnings/cash-flow expectations for offshore drillers and often trigger multi-day momentum follow-through.",
        "sources": [
          {
            "title": "Transocean's New Deals in Brazil & Norway Add $168M to Firm Backlog",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-06"
          },
          {
            "title": "Transocean secures Mykonos contract, Enabler extension worth $168m backlog",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-06"
          }
        ]
      },
      "scores": {
        "technical": 8.0,
        "catalyst": 6.0,
        "options": 3.0,
        "sentiment": 4.0
      },
      "composite_score": 5.25,
      "evidence": {
        "technical": {
          "within_5pct_52w_high": true,
          "resistance_level": null,
          "volume_ratio_3d_to_20d": 0.64,
          "rsi14": 64.04,
          "above_ma10_ma20_ma50": true,
          "realized_vol_5d_ann_pct": 23.47
        },
        "options": {
          "call_put_ratio": null,
          "unusual_volume_multiple": null,
          "largest_bullish_premium_usd": null,
          "iv_rank": null,
          "notable_contracts": []
        },
        "sentiment": {
          "twitter": {
            "mention_velocity_vs_7d": null,
            "quality_accounts_est": null,
            "bullish_pct_est": null
          },
          "reddit": {
            "mention_velocity": null,
            "upvote_ratio_est": null
          },
          "stocktwits": {
            "bull_bear_ratio_est": null
          },
          "news_tone": "positive"
        }
      },
      "risk_factors": [
        "High sensitivity to oil price and offshore capex sentiment; macro can overwhelm contract news.",
        "Low-priced stock can be more volatile and headline-driven; gap risk elevated."
      ],
      "confidence": "SPECULATIVE",
      "data_gaps": [
        "Options data unavailable in packet; options score capped at 3.0.",
        "Social sentiment data unavailable in packet; sentiment score capped at 4.0.",
        "No confirmed scheduled catalyst date/time within next 7 trading days; catalyst is recent newsflow.",
        "5-trading-day % move not provided; cannot enforce >15% exclusion rule."
      ]
    },
    {
      "rank": 3,
      "ticker": "PSX",
      "name": "Phillips 66",
      "exchange": "NYSE",
      "sector": "Energy",
      "current_price": 139.8800048828125,
      "market_cap_usd": 55647907840,
      "avg_dollar_volume_20d": 299067804.0464783,
      "asof_price_utc": "2025-12-09T00:00:00Z",
      "target": {
        "horizon_trading_days": 7,
        "upside_threshold_pct": 10,
        "target_price_for_10pct": 153.868005,
        "base_case_upside_pct_range": [
          10,
          15
        ],
        "bear_case_note": "If deal terms are viewed negatively (integration/capex/regulatory) or refining margins weaken; failure to hold recent breakout levels."
      },
      "primary_catalyst": {
        "title": "Acquisition of Lindsey Oil Refinery (England) / refining narrative",
        "key_date_local": "2026-01-13",
        "timing": "Anytime",
        "why_it_matters": "Deal announcements can re-rate refiners on expected throughput, margin capture, and strategic positioning; can catalyze follow-through if investors view it as accretive.",
        "sources": [
          {
            "title": "Phillips 66 (PSX) Agrees to Acquire Lindsey Oil Refinery in England",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-13"
          },
          {
            "title": "Why Phillips 66 (PSX) Is Up 8.9% After Lindsey Refinery Deal And Refining Gains",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-10"
          }
        ]
      },
      "scores": {
        "technical": 6.0,
        "catalyst": 6.0,
        "options": 3.0,
        "sentiment": 4.0
      },
      "composite_score": 4.75,
      "evidence": {
        "technical": {
          "within_5pct_52w_high": true,
          "resistance_level": null,
          "volume_ratio_3d_to_20d": 0.95,
          "rsi14": 53.45,
          "above_ma10_ma20_ma50": true,
          "realized_vol_5d_ann_pct": 12.97
        },
        "options": {
          "call_put_ratio": null,
          "unusual_volume_multiple": null,
          "largest_bullish_premium_usd": null,
          "iv_rank": null,
          "notable_contracts": []
        },
        "sentiment": {
          "twitter": {
            "mention_velocity_vs_7d": null,
            "quality_accounts_est": null,
            "bullish_pct_est": null
          },
          "reddit": {
            "mention_velocity": null,
            "upvote_ratio_est": null
          },
          "stocktwits": {
            "bull_bear_ratio_est": null
          },
          "news_tone": "positive"
        }
      },
      "risk_factors": [
        "M&A execution/regulatory risk; market may demand more detail on valuation and capex.",
        "Refining margin volatility; sector can reverse quickly with crude/product spread changes."
      ],
      "confidence": "SPECULATIVE",
      "data_gaps": [
        "Options data unavailable in packet; options score capped at 3.0.",
        "Social sentiment data unavailable in packet; sentiment score capped at 4.0.",
        "No confirmed scheduled catalyst date/time within next 7 trading days beyond deal/newsflow.",
        "5-trading-day % move not provided; cannot enforce >15% exclusion rule."
      ]
    },
    {
      "rank": 4,
      "ticker": "LUV",
      "name": "Southwest Airlines Co.",
      "exchange": "NYSE",
      "sector": "Industrials",
      "current_price": 38.150001525878906,
      "market_cap_usd": 22688108544,
      "avg_dollar_volume_20d": 266202844.24331665,
      "asof_price_utc": "2025-12-09T00:00:00Z",
      "target": {
        "horizon_trading_days": 7,
        "upside_threshold_pct": 10,
        "target_price_for_10pct": 41.965002,
        "base_case_upside_pct_range": [
          10,
          16
        ],
        "bear_case_note": "If airline earnings read-through turns negative (pricing/costs) or the upgrade is faded; breakdown below short-term trend."
      },
      "primary_catalyst": {
        "title": "Analyst action: JPMorgan double-upgrade + new street-high price target",
        "key_date_local": "2026-01-09",
        "timing": "Anytime",
        "why_it_matters": "A high-profile double-upgrade with a new street-high target can trigger incremental institutional demand and short-term momentum, especially if reinforced by sector earnings read-through.",
        "sources": [
          {
            "title": "JPM double-upgrades Southwest Airlines shares, sets new street high price target",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-09"
          },
          {
            "title": "A Look At Southwest Airlines (LUV) Valuation After JPMorgan Double Upgrade And 2026 Guidance Optimism",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-10"
          }
        ]
      },
      "scores": {
        "technical": 8.0,
        "catalyst": 5.0,
        "options": 3.0,
        "sentiment": 4.0
      },
      "composite_score": 5.0,
      "evidence": {
        "technical": {
          "within_5pct_52w_high": true,
          "resistance_level": null,
          "volume_ratio_3d_to_20d": 1.58,
          "rsi14": 86.98,
          "above_ma10_ma20_ma50": true,
          "realized_vol_5d_ann_pct": 37.23
        },
        "options": {
          "call_put_ratio": null,
          "unusual_volume_multiple": null,
          "largest_bullish_premium_usd": null,
          "iv_rank": null,
          "notable_contracts": []
        },
        "sentiment": {
          "twitter": {
            "mention_velocity_vs_7d": null,
            "quality_accounts_est": null,
            "bullish_pct_est": null
          },
          "reddit": {
            "mention_velocity": null,
            "upvote_ratio_est": null
          },
          "stocktwits": {
            "bull_bear_ratio_est": null
          },
          "news_tone": "positive"
        }
      },
      "risk_factors": [
        "Airline group is highly sensitive to macro, fuel prices, and demand signals; sector correlation risk is high.",
        "RSI is very elevated (overbought risk); pullback risk increases if catalysts don't extend."
      ],
      "confidence": "SPECULATIVE",
      "data_gaps": [
        "Options data unavailable in packet; options score capped at 3.0.",
        "Social sentiment data unavailable in packet; sentiment score capped at 4.0.",
        "Catalyst is not a scheduled company event; it is analyst-driven and may be partially priced.",
        "5-trading-day % move not provided; cannot enforce >15% exclusion rule."
      ]
    },
    {
      "rank": 5,
      "ticker": "KRYS",
      "name": "Krystal Biotech, Inc.",
      "exchange": "NASDAQ",
      "sector": "Healthcare",
      "current_price": 234.63999938964844,
      "market_cap_usd": 8465245696,
      "avg_dollar_volume_20d": 61011570.19035339,
      "asof_price_utc": "2025-12-09T00:00:00Z",
      "target": {
        "horizon_trading_days": 7,
        "upside_threshold_pct": 10,
        "target_price_for_10pct": 258.104,
        "base_case_upside_pct_range": [
          10,
          22
        ],
        "bear_case_note": "If follow-on FDA/clinical updates fail to materialize or are interpreted negatively; biotech risk-off tape can compress multiples quickly."
      },
      "primary_catalyst": {
        "title": "Clinical/FDA-related update newsflow (KB407 CF gene therapy data + FDA study filing)",
        "key_date_local": "2026-01-10",
        "timing": "Anytime",
        "why_it_matters": "Biotech names can move sharply on incremental clinical/regulatory updates; recent positive data and an FDA study filing can sustain momentum if additional details/next steps emerge.",
        "sources": [
          {
            "title": "Krystal Biotech (KRYS) Is Up 5.9% After Positive KB407 CF Gene Therapy Data And FDA Study Filing",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-10"
          },
          {
            "title": "Krystal Biotech Touts Positive KB407 CF Gene Therapy Data, Eyes Repeat Dosing and Registrational Path",
            "publisher": "",
            "url": "",
            "published_at": "2026-01-09"
          }
        ]
      },
      "scores": {
        "technical": 8.0,
        "catalyst": 5.0,
        "options": 3.0,
        "sentiment": 4.0
      },
      "composite_score": 5.0,
      "evidence": {
        "technical": {
          "within_5pct_52w_high": true,
          "resistance_level": null,
          "volume_ratio_3d_to_20d": 1.59,
          "rsi14": 88.71,
          "above_ma10_ma20_ma50": true,
          "realized_vol_5d_ann_pct": 35.37
        },
        "options": {
          "call_put_ratio": null,
          "unusual_volume_multiple": null,
          "largest_bullish_premium_usd": null,
          "iv_rank": null,
          "notable_contracts": []
        },
        "sentiment": {
          "twitter": {
            "mention_velocity_vs_7d": null,
            "quality_accounts_est": null,
            "bullish_pct_est": null
          },
          "reddit": {
            "mention_velocity": null,
            "upvote_ratio_est": null
          },
          "stocktwits": {
            "bull_bear_ratio_est": null
          },
          "news_tone": "positive"
        }
      },
      "risk_factors": [
        "Binary biotech interpretation risk: small details in data/regulatory path can reverse momentum quickly.",
        "RSI is extremely elevated (overbought); higher probability of sharp pullbacks even in uptrends."
      ],
      "confidence": "SPECULATIVE",
      "data_gaps": [
        "Options data unavailable in packet; options score capped at 3.0.",
        "Social sentiment data unavailable in packet; sentiment score capped at 4.0.",
        "No confirmed scheduled FDA decision date within next 7 trading days; catalyst treated as ongoing newsflow.",
        "5-trading-day % move not provided; cannot enforce >15% exclusion rule."
      ]
    }
  ]
}